Evidence map›Paper›PMID 40076400›Full record

ReviewMolecules (Basel, Switzerland)2025

Polysaccharides with Arabinose: Key Players in Reducing Chronic Inflammation and Enhancing Immune Health in Aging.

Patricia Pantoja Newman, Brenda Landvoigt Schmitt, Rafael Moura Maurmann, Brandt D Pence

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Primary Metabolites in ThreeLife (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Patricia Pantoja NewmanCollege of Health Sciences, University of Memphis, Memphis, TN 38152, USA.ORCID 0000-0002-4621-7059
Brenda Landvoigt SchmittCollege of Health Sciences, University of Memphis, Memphis, TN 38152, USA.ORCID 0000-0001-5823-2611
Rafael Moura MaurmannCollege of Health Sciences, University of Memphis, Memphis, TN 38152, USA.ORCID 0000-0003-1759-1778
Brandt D PenceCollege of Health Sciences, University of Memphis, Memphis, TN 38152, USA.

Funding

Mitochondrial determinants of monocyte dysfunction in agingR15AG078906 · NIA · UNIVERSITY OF MEMPHIS · PI PENCE, BRANDT D. · 2022 to 2022
$414k
NIA NIH HHS R15 AG078906NIA NIH HHS R15AG078906
6 · The paper itself

Abstract

Aging is associated with a decline in physiological performance leading to increased inflammation and impaired immune function. Polysaccharides (PLs) found in plants, fruits, and fungi are emerging as potential targets for therapeutic intervention, but little is known about their effects on chronic inflammation and aging. This review aims to highlight the current advances related to the use of PLs, with the presence of arabinose, to attenuate oxidative stress and chronic and acute inflammation, and their immunomodulatory effects associated with antioxidant status in monocytes, macrophages, and neutrophil infiltration, and leukocyte rolling adhesion in neutrophils. In addition, recent studies have shown the importance of investigating the 'major' monosaccharide, such as arabinose, present in several of these polysaccharides, and with described effects on gut microbiome, glucose, inflammation, allergy, cancer cell proliferation, neuromodulation, and metabolic stress. Perspectives and opportunities for further investigation are provided. By promoting a balanced immune response and reducing inflammation, PLs with arabinose or even arabinose per se may alleviate the immune dysregulation and inflammation seen in the elderly, therefore providing a promising strategy to mitigate a variety of diseases.

Indexed as

AgingArabinoseInflammationPolysaccharidesAnimalsAntioxidantsChronic DiseaseHumansOxidative StressAntioxidantsArabinosePolysaccharidesarabinoseinflammaginginnate immune systempolysaccharide

Identifiers

PMID40076400
PMCPMC11901799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.